Back to Clinical Trials Overview

Back To Cancer Clinical Trials

Your search for "Head and Neck" returned 8 results:


A Phase 2a, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Two Different Doses of ALD518 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concomitant Chemotherapy and Radiotherapy
Principal Investigator(s): Marcelo R Bonomi

Phase I Study of Cabazitaxel- PF Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Principal Investigator(s): Krzysztof J. Misiukiewicz

An Open-label Phase 2 Study of ACE-041 in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Principal Investigator(s): Marshall Posner

A Randomized, Double-Blind, Phase 2 Safety Study of Cetuximab, Using ImClone versus Boehringer Ingelheim Manufacturing Processes, in Combination with Cisplatin or Carboplatin and 5-Fluorouracil in the First-Line Treatment of Patients with Locoregionally Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Principal Investigator(s): Krzysztof J. Misiukiewicz

A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Principal Investigator(s): Richard Bakst

A Randomized Phase III Clinical Trial Comparing Reduced and Standard Radiation Therapy Doses for Locally Advanced HPV 16 Positive Oropharynx Cancer
Principal Investigator(s): Marshall Posner

Randomized, double-blind, multicenter two-stage adaptive Phase 3 study of intravenous administration of Reolysin® (Reovirus Type 3 Dearing) in combination with Paclitaxel and Carboplatin versus the chemotherapy alone in patients with metastatic or recurrent squamous cell carcinoma of the head and neck who have progressed on or after prior platinum-based chemotherapy
Principal Investigator(s): Krzysztof J. Misiukiewicz

Phase II Trial Using RAD001 for Patients with Radioiodine Refractory Thyroid Cancer
Principal Investigator(s): Krzysztof J. Misiukiewicz